HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis.

AbstractOBJECTIVE:
To examine the efficacy and safety of antibiotic treatments for reactive arthritis (ReA).
METHODS:
We did a systematic review and metaanalysis of randomized controlled trials of antibiotics for treatment of ReA. We searched electronic databases and conference proceedings up to November 2011. Included trials reported on remission, joint counts, and pain or patient global scores in any language.
RESULTS:
Twelve trials were eligible for inclusion and 10 provided data for metaanalysis. The pooled relative risk of failure to achieve remission from a random effects model showed no significant benefit of antibiotic treatment on remission (7 trials, 375 participants, RR 0.74, 95% CI 0.49-1.10); however, substantial heterogeneity was observed (I(2) = 76.3%, p < 0.0001). The treatment effect did not differ significantly by the type of organism triggering the ReA (chlamydia, 4 trials, RR 0.80, 95% CI 0.63-1.03, vs other microorganisms, 5 trials, RR 0.72, 95% CI 0.29-1.79, metaregression p = 0.477) or use of combination antibiotics (monotherapy, 6 trials, RR 0.70, 95% CI 0.39-1.26, vs combination therapy, 1 trial, RR 0.79, 95% CI 0.63-0.99, metaregression p = 0.466). When unblinded trials were excluded, the treatment effect was attenuated and heterogeneity decreased (RR 0.87, 95% CI 0.70-1.10, I(2) = 32.8%, p = 0.19). No significant effects of antibiotic treatment were observed on joint counts, pain, or patient global scores; however, antibiotics were associated with a 97% increase in gastrointestinal adverse events.
CONCLUSION:
Trials of antibiotic treatment for ReA have produced heterogeneous results that may be related to differences in study design. The efficacy of antibiotics is uncertain.
AuthorsClaire E Barber, Joseph Kim, Robert D Inman, John M Esdaile, Matthew T James
JournalThe Journal of rheumatology (J Rheumatol) Vol. 40 Issue 6 Pg. 916-28 (Jun 2013) ISSN: 0315-162X [Print] Canada
PMID23588936 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Chemical References
  • Anti-Bacterial Agents
  • PHB2 protein, human
  • Prohibitins
Topics
  • Anti-Bacterial Agents (adverse effects, therapeutic use)
  • Arthritis, Reactive (drug therapy)
  • Humans
  • Prohibitins
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: